Among patients with COPD, it is expected that 1-4% will be found to have the Pi*ZZ genotype, which is why the WHO recommends AAT testing for all patients diagnosed with COPD.10 This evidence concerns the gene SERPINA1 and chronic obstructive pulmonary disease.